UM

Browse/Search Results:  1-4 of 4 Help

Filters    
Selected(0)Clear Items/Page:    Sort:
Oral delivery of a nanocrystal formulation of schisantherin a with improved bioavailability and brain delivery for the treatment of Parkinson's disease Journal article
Molecular Pharmaceutics, 2016,Volume: 13,Issue: 11,Page: 3864-3875
Authors:  Chen T.;  Li C.;  Li Y.;  Yi X.;  Lee S.M.-Y.;  Zheng Y.
Favorite  |  View/Download:4/0  |  Submit date:2018/11/06
Brain Delivery  Dissolution  Nanocrystals  Oral Bioavailability  Parkinson's Disease (Pd)  
A redox-sensitive and RAGE-targeting nanocarrier for hepatocellular carcinoma therapy Journal article
Molecular Pharmaceutics, 2016,Volume: 13,Issue: 11,Page: 3613-3625
Authors:  Fang X.-B.;  Xu Y.-Q.;  Chan H.-F.;  Wang C.-M.;  Zheng Q.;  Xiao F.;  Chen M.-W.
Favorite  |  View/Download:12/0  |  Submit date:2018/11/07
Hcc  Oridonin  Pluronic F68  Rage  Redox-sensitivity  
Codelivery of Doxorubicin and shAkt1 by Poly(ethylenimine)-Glycyrrhetinic Acid Nanoparticles to Induce Autophagy-Mediated Liver Cancer Combination Therapy Journal article
Molecular Pharmaceutics, 2016,Volume: 13,Issue: 4,Page: 1298-1307
Authors:  Wang F.-Z.;  Xing L.;  Tang Z.-H.;  Lu J.-J.;  Cui P.-F.;  Qiao J.-B.;  Jiang L.;  Jiang H.-L.;  Zong L.
Favorite  |  View/Download:1/0  |  Submit date:2018/12/28
Autophagy  Combination Therapy  Glycyrrhetinic Acid  Liver Cancer Targeting  Self-assembled  
Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy Journal article
Molecular Pharmaceutics, 2016,Volume: 13,Issue: 3,Page: 699
Authors:  Cai Y.;  Xu Y.;  Chan H.F.;  Fang X.;  He C.;  Chen M.
Favorite  |  View/Download:10/0  |  Submit date:2018/10/30
Anti-hcc  Delivery Systems  Ga  Liver-targeting